Posts by: Alice Melão

News

Inhibiting the HDAC6 enzyme with an experimental agent called SW-100 improved memory and lowered learning impairments in a mouse model of fragile X syndrome (FXS), a study has shown. ... Read more

January 3, 2019January 3, 2019

FMR1 Mutations Linked to Early Atypical Temperament, Study Shows

News

Mutations in the FMR1 gene are associated with atypical temperament that can emerge as early as infancy, particularly among infants with fragile X syndrome, a study has shown. The ... Read more

December 18, 2018December 18, 2018

Cannabidiol Gel ZYN002 Shows Sustained Benefits in Children and Teens with Fragile X, Zynerba Reports

News

One year of treatment with the cannabidiol gel ZYN002, being developed by Zynerba Pharmaceuticals, can provide sustained benefit to young patients with fragile X syndrome, data from a Phase 2 ... Read more

September 27, 2018September 27, 2018

Cellular ‘Cleaning System’ a Possible Therapeutic Target for Fragile X, Mouse Study Finds

News

Autophagy, a natural process that acts as a “cleaning system” for cells, plays an important role in regulating the activity of brain cells and cognitive deficits associated with fragile ... Read more

September 20, 2018September 20, 2018

Human iPSCs Beneficial for Study of Autism Spectrum Disorders, but Limitations Still Exist, Review Says

News

Human induced pluripotent stem cells, also known as iPSCs, are valuable tools for discovering new targets and treatment strategies for several diseases, including autism spectrum disorders, despite some limitations ... Read more

July 31, 2018July 31, 2018

Ovid Starts Phase 2 ROCKET Trial Testing OV101 in Adolescents with Fragile X Syndrome

News

Ovid Therapeutics has initiated the Phase 2 ROCKET clinical trial to assess the safety, tolerability, and efficacy of OV101 (gaboxadol) as a treatment for adolescents and young adults with ... Read more

May 8, 2018May 8, 2018

Fragile X Syndrome Linked to Impaired Brain White Matter Development, Researchers Say

News

Babies with fragile X syndrome have less-developed brain white matter compared to those without the syndrome, according to researchers. Their study, “Development of White Matter Circuitry in Infants With ... Read more

April 26, 2018April 26, 2018

Brain Activity Alterations Cause Hearing Problems in Fragile X Syndrome, Mouse Study Finds

News

Mice that lack the gene responsible for fragile X syndrome have similar changes in brain activity in the auditory cortex as those reported in humans. The study with that finding, ... Read more

April 10, 2018April 10, 2018

Increased Protein Synthesis Is a Biomarker of Fragile X Syndrome, Study Suggests

News

Patients with fragile X syndrome have faster protein synthesis and increased protein levels than healthy people, according to a recent study. These findings suggest that protein synthesis alterations could ... Read more

March 1, 2018March 1, 2018

GW Announces Increased Focus on Developing GWP42006 Therapy for Fragile X, Other Disorders

News

GW Pharmaceuticals is going to increase its focus on the development of its investigational, cannabinoid-based therapy GWP42006 to treat autism spectrum disorders (ASD), including Fragile X, the company announced. ... Read more

Posts by: Alice Melão

Alice Melão

Inhibiting HDAC6 Enzyme Has Potential for Treating FRX, Mouse Study Finds

FMR1 Mutations Linked to Early Atypical Temperament, Study Shows

Cannabidiol Gel ZYN002 Shows Sustained Benefits in Children and Teens with Fragile X, Zynerba Reports

Cellular ‘Cleaning System’ a Possible Therapeutic Target for Fragile X, Mouse Study Finds

Human iPSCs Beneficial for Study of Autism Spectrum Disorders, but Limitations Still Exist, Review Says

Ovid Starts Phase 2 ROCKET Trial Testing OV101 in Adolescents with Fragile X Syndrome

Fragile X Syndrome Linked to Impaired Brain White Matter Development, Researchers Say

Brain Activity Alterations Cause Hearing Problems in Fragile X Syndrome, Mouse Study Finds

Increased Protein Synthesis Is a Biomarker of Fragile X Syndrome, Study Suggests

GW Announces Increased Focus on Developing GWP42006 Therapy for Fragile X, Other Disorders

Pin It on Pinterest